-
-
-
-
KGM® Keratinocyte Growth Medium BulletKit®Catalog #: CC-3111
KGM® Keratinocyte Growth Medium BulletKit® Culture System contains KBM® Basal Medium (CC-3101) and KGM® SingleQuot® supplements (CC-4131) required for growth of human keratinocytes.
Sales unit: kit -
Chondrocyte ReagentPack™ Subculture ReagentsCatalog #: CC-3233Chondrocyte ReagentPackTM Subculture ReagentSales unit: kit
-
hFGF – Human Fibroblastic Growth Factor, 1 mLCatalog #: CC-4068hFGF, Human Fibroblast Growth Factors, 1 mLSales unit: Vial
-
ProSieve® Color Protein MarkerCatalog #: 50550
ProSieve® Color Protein Marker, 10-190 kDa, 500 µL
Discontinuation notification: Based on our product lifecycle management review to maintain high service levels across our portfolios, this product will be discontinued by July 21, 2025.
Sales unit: each -
ProSieve® Color Protein MarkerCatalog #: 50552
ProSieve® Color Protein Marker, 10-190 kDa, 100 µL
Discontinuation notification: Based on our product lifecycle management review to maintain high service levels across our portfolios, this product will be discontinued by July 21, 2025
Sales unit: each -
KGM™-2 Keratinocyte Growth Medium-2 BulletKit™, Calcium FreeCatalog #: CC-3108
This product has been discontinued. The suggested alternative is KGM-GoldTM Keratinocyte Growth BulletkitTM, calcium-free (Catalog # 00195769), and/or its components.
Sales unit: kit -
SAGMTM Small Airway Epithelial Cell Growth Medium BulletKit®Catalog #: CC-3118
Culture system containing SABMTM Basal Medium and SAGMTM SingleQuots® supplements required for growth of Small Airway Epithelial cells
Sales unit: kit
-
The Compendia are ready. Are you?Explore the new regulatory landscape for rFC and MAT as the assays gain global approval. rFC and MAT are no longer the 'alternatives'.
-
Generation of hiPSCs from Cord Blood Cells With the 4D-Nucleofector® SystemA scientific paper by Lonza, outlining the generation of iPSCs from Cord Blood Cells using the 4D-Nucleofector® System
-
Webinar - Hepatocytes in the drug development pipelineOverview of how primary hepatocytes are used in drug development
-
Advancing Bone Disease Research – Dissociated Rat Calvariae Osteoblasts Display Optimal Mineralization and Are Easily Transfected Using NucleofectionThe data provided in this white paper show the quality and sensitivity of cryopreserved dissociated rat calvariae osteoblasts for in vitro studies. Furthermore, application of the 4D-Nucleofector™ System for efficient transfection of dissociated osteoblasts represents a significant advantage for investigating bone biology.
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
PYROSTAR™ ES-F Series BrochureThe PYROSTAR™ ES-F series of reagents are endotoxin-specific and unreactive to β-D-Glucan
-
Confidence for adopting the rFC method in your labFact-based reference materials for those companies who are considering adopting the rFC method in their labs.
-
Troubleshooting Guide - PYROGENT® Gel Clot LAL AssayMost problems encountered in the use of the PYROGENT® Gel Clot Limulus Amebocyte Lysate (LAL) Assay fall into two basic categories - no firm gels are observed in reaction tubes where firm gels are expected or firm gels form in reaction tubes, which are expected to yield negative results. This Tech Tip takes a deeper look into each of these categories and provides troubleshooting guidance.
-
Expanded HUVECs for High-throughput ScreeningHUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
-
NPCs Hepatic Non-Parenchymal CellsThese additional liver cell types provide a complete building set supporting complex cell culture modeling. Applications include developing more physiologically relevant in vitro models for complex liver diseases and toxicity testing of new drugs and chemicals.